These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 18666137)

  • 1. Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
    Wu F; Xia Z; Qu Y; Tang Y; Cao D; Sun P; Christiani DC
    Am J Ind Med; 2008 Nov; 51(11):843-51. PubMed ID: 18666137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
    Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
    Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymorphisms of FAS and FASL genes and susceptibility of silicosis].
    Wu F; Qu YB; Sun P; Ji F; Qiu YL; Miao WB; Wang W; Jin RF; Xia ZL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):7-11. PubMed ID: 18302883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
    J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.
    Vishnoi M; Pandey SN; Choudhuri G; Mittal B
    Cancer Genet Cytogenet; 2008 Oct; 186(2):63-8. PubMed ID: 18940468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
    Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH
    Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
    Jung YJ; Kim YJ; Kim LH; Lee SO; Park BL; Shin HD; Lee HS
    Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis.
    Zhang H; Sun XF; Synnerstad I; Rosdahl I
    Cancer J; 2007; 13(4):233-7. PubMed ID: 17762757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
    Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
    Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
    Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D
    J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
    Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
    Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer.
    Singh H; Sachan R; Goel H; Mittal B
    BJOG; 2008 Apr; 115(5):633-8. PubMed ID: 18333945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
    Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
    J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris.
    Li H; Gao L; Shen Z; Li CY; Li K; Li M; Lv YJ; Li CX; Gao TW; Liu YF
    Arch Dermatol Res; 2008 Sep; 300(8):425-33. PubMed ID: 18330586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
    Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.